Beta-adrenergic blockers

Preview

For many years, therapeutic options that involved beta-adrenergic blocking agents were limited in the United States. However, newly introduced beta blockers have considerably expanded the range of choices. These agents differ from each other in subtle but clinically important ways, and the clinician needs to understand these differences to make the best selection. In this article, Drs Vlietstra and McGoon compare the six beta blockers currently on the US market.